A review of Ganoderma lucidum active compounds and their biological applications

[1]  Soares, A. A., de Sá-Nakanishi, A. B., Bracht, A., da Costa, S. M. G., Koehnlein, E. A., de Souza, C. G. M. &  Peralta, R. M. (2013). Hepatoprotective effects of mushrooms. Molecules. 18(7), 7609-7630.

[2]  González, A., Atienza, V., Montoro, A. &  Soriano, J. M. (2020). Use of Ganoderma lucidum (Ganodermataceae, Basidiomycota) as radioprotector. Nutrients. 12(4), 1143.

[3]  Atienza, V., Montoro, A., Sebastiá, N. &  Soriano, J. (2013). Natural organisms with effect radioprotective. The Latest Advances in Radioprotectors of Natural Origin; Soriano, JM, Montoro, A., Eds, 115-205.

[4]  Wachtel-Galor, S., Yuen, J., Buswell, J. A. &  Benzie, I. F. F. (2011). Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Eds.; CRC Press/Taylor & Francis: Boca Ratón, FL, USA: Eds.; CRC Press/Taylor & Francis: Boca Ratón, FL, USA, pp. 175-200.

[5]  Arora, D. (1986). Mushroom Demystified: A Comprehensive Guide to the Fleshy Fungi. 2nd edition. Berkeley; Ten Speed Press.

[6]  Alexopoulos, C., Mins, W. &  Blackwell, M. (1996). Introductory Mycology.–4th. Ed. New York: Jhon Winley & SONS. ed: Inc.

[7]  Commission, C. P. (2015). Chinese pharmacopoeia. China Medical Science Press: Beijing, China. 1(191-193.

[8]  Ćilerdžić, J. L., Stajić, M. M. &  Vukojević, J. B. (2017). Ganoderma lucidum-from tradition to modern medicine. Zbornik Matice srpske za prirodne nauke, 133), 151-161.

[9]  Li, J., Zhang, J., Chen, H., Chen, X., Lan, J. &  Liu, C. (2013). Complete mitochondrial genome of the medicinal mushroom Ganoderma lucidum. Plos one. 8(8), e72038.

[10] Al-Azzawi, R. R. A. & Bandr, L. K. (2023). Effect of Adding Lion’s Mane Mushroom Hericium erinaceus and Reishi Mushrooms Ganoderma lucidum to Broiler Diets on some Physiological, Immunological Characteristics and Oxidation Indicators of Meat. in IOP Conference Series: Earth and Environmental Science.

[11] Lu, S.-Y., Shi, Q.-Q., Peng, X.-R., Zhou, L., Li, X.-N. &  Qiu, M.-H. (2020). Isolation of benzolactones, Ganodumones A–F from Ganoderma lucidum and their antibacterial activities. Bioorganic Chemistry. 98(103723.

[12] Reddy, E. P. (2018). Phytochemical Analysis and Antifungal Activity of Ganoderma lucidum. Indian Journal of Public Health Research & Development. 9(12), 130-135.

[13] Alghonaim, M. I., Alsalamah, S. A., Alsolami, A. &  Ghany, T. A. (2023). Characterization and efficiency of Ganoderma lucidum biomass as an antimicrobial and anticancer agent. BioResources. 18(4), 8037.

[14] Cho, J. Y., Sadiq, N. B., Kim, J.-C., Lee, B., Hamayun, M., Lee, T. S., . . . Kim, H.-Y. (2021). Optimization of antioxidant, anti-diabetic, and anti-inflammatory activities and ganoderic acid content of differentially dried Ganoderma lucidum using response surface methodology. Food Chemistry. 335(127645.

[15] Adeyi, A. O., Awosanya, S. A., Adeyi, O. E., James, A. S. &  Adenipekun, C. O. (2021). Ganoderma lucidum ethanol extract abrogates metabolic syndrome in rats: In vivo evaluation of hypoglycemic, hypolipidemic, hypotensive and antioxidant properties. Obesity Medicine. 22(100320.

[16] Rahman, M. A., Hossain, M. S., Abdullah, N. &  Aminudin, N. (2020). Validation of Ganoderma lucidum against hypercholesterolemia and Alzheimer’s disease. European Journal of Biological Research. 10(4), 314-325.

[17] Chen, S., Guan, X., Yong, T., Gao, X., Xiao, C., Xie, Y., . . . Wu, Q. (2022). Structural characterization and hepatoprotective activity of an acidic polysaccharide from Ganoderma lucidum. Food chemistry: X. 13(100204.

[18] Shaher, F., Qiu, H., Wang, S., Hu, Y., Wang, W., Zhang, Y., . . . Alenezi, S. K. (2020). Associated targets of the antioxidant cardioprotection of Ganoderma lucidum in diabetic cardiomyopathy by using open targets platform: a systematic review. BioMed Research International. 2020(

[19] Luz, D. A., Pinheiro, A. M., Fontes‐Júnior, E. A. &  Maia, C. S. (2023). Neuroprotective, neurogenic, and anticholinergic evidence of Ganoderma lucidum cognitive effects: Crucial knowledge is still lacking. Medicinal Research Reviews. 43(5), 1504-1536.

[20] Oke, M., Afolabi, F., Oyeleke, O., Kilani, T., Adeosun, A., Olanbiwoninu, A. &  Adebayo, E. (2022). Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa. Frontiers in Pharmacology. 13(952027.

[21] Borchers, A. T., Krishnamurthy, A., Keen, C. L., Meyers, F. J. &  Gershwin, M. E. (2008). The immunobiology of mushrooms. Experimental biology and medicine. 233(3), 259-276.

[22] Yuen, J. W. & Gohel, M. D. I. (2005). Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutrition and cancer. 53(1), 11-17.

[23] Ye, L., Liu, S., Xie, F., Zhao, L. &  Wu, X. (2018). Enhanced production of polysaccharides and triterpenoids in Ganoderma lucidum fruit bodies on induction with signal transduction during the fruiting stage. PLoS One. 13(4), e0196287.

[24] Cör Andrejč, D., Knez, Ž. &  Knez Marevci, M. (2022). Antioxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. Frontiers in pharmacology. 13(934982.

[25] Xu, G.-B., Xiao, Y.-H., Zhang, Q.-Y., Zhou, M. &  Liao, S.-G. (2018). Hepatoprotective natural triterpenoids. European journal of medicinal chemistry. 145(691-716.

[26] Ćilerdžić, J. L., Sofrenić, I. V., Tešević, V. V., Brčeski, I. D., Duletić‐Laušević, S. N., Vukojević, J. B. &  Stajić, M. M. (2018). Neuroprotective potential and chemical profile of alternatively cultivated Ganoderma lucidum basidiocarps. Chemistry & Biodiversity. 15(5), e1800036.

[27] Kubota, T., Asaka, Y., Miura, I. &  Mori, H. (1982). Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes from Ganoderma lucidum (FR.) KARST. Helvetica Chimica Acta. 65(2), 611-619.

[28] Kareem, H. J. & Al-Araji, A. M. (2025). Synergistic effect of Ganoderma lucidum Triterpenoids and biosynthesized Zinc Oxide nanoparticles against some dermatophytes. Nanomedicine Research Journal. 9(3), 228-242.

[29] Xia, Q., Zhang, H., Sun, X., Zhao, H., Wu, L., Zhu, D., . . . Mao, X. (2014). A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules. 19(11), 17478-17535.

[30] Liang, C., Tian, D., Liu, Y., Li, H., Zhu, J., Li, M., . . . Xia, J. (2019). Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y. European Journal of Medicinal Chemistry. 174(130-141.

[31] Lin, Z. & Yang, B., Ganoderma and Health Biology, Chemistry and Industry. Advances in Experimental Medicine and Biology, 2019.

[32] Chen, Y., Xie, M.-Y. &  Gong, X.-F. (2007). Microwave-assisted extraction used for the isolation of total triterpenoid saponins from Ganoderma atrum. Journal of Food Engineering. 81(1), 162-170.

[33] Zhang, J., Duan, J., Liang, Z., Zhang, W., Zhang, L., Huo, Y. &  Zhang, Y. (2006). Analysis of triterpenoids in fruiting bodies of Ganoderma lucidum with off-line supercritical fluid extraction-high performance liquid chromatography system. Chinese Journal of Analytical Chemistry. 34(4), 447-450.

[34] Sanodiya, B. S., Thakur, G. S., Baghel, R. K., Prasad, G. &  Bisen, P. (2009). Ganoderma lucidum: a potent pharmacological macrofungus. Current pharmaceutical biotechnology. 10(8), 717-742.

[35] Huie, C. W. & Di, X. (2004). Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components. Journal of Chromatography B. 812(1-2), 241-257.

[36] Zhu, L., Luo, X., Tang, Q., Liu, Y., Zhou, S., Yang, Y. &  Zhang, J. (2013). Isolation, purification, and immunological activities of a low-molecular-weight polysaccharide from the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher basidiomycetes). International Journal of Medicinal Mushrooms. 15(4),

[37] Lu, J., He, R., Sun, P., Zhang, F., Linhardt, R. J. &  Zhang, A. (2020). Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review. International journal of biological macromolecules. 150(765-774.

[38] Huang, S.-Q., Li, J.-W., Wang, Z., Pan, H.-X., Chen, J.-X. &  Ning, Z.-X. (2010). Optimization of alkaline extraction of polysaccharides from Ganoderma lucidum and their effect on immune function in mice. Molecules. 15(5), 3694-3708.

[39] Kang, Q., Chen, S., Li, S., Wang, B., Liu, X., Hao, L. &  Lu, J. (2019). Comparison on characterization and antioxidant activity of polysaccharides from Ganoderma lucidum by ultrasound and conventional extraction. International journal of biological macromolecules. 124(1137-1144.

[40] Siwulski, M., Sobieralski, K., Golak-Siwulska, I., Sokół, S. &  Sękara, A. (2015). (Curt.: Fr.) Karst.–health-promoting properties. A review. Herba Polonica. 61(3), 105-118.

[41] AL-Sudani, E. A. & Alash, S. A. (2019). Prevalence of Urinary Tract Infections in Adult and Child Patients. Indian Journal of Public Health. 10(11), 1861.

[42] Abdelmohsen, G., Dawoud, G. T. &  Mohamed, M. S. (2020). Investigation of the biochemical and ultrastructural mechanisms underlying the antimicrobial activity of Mimusops spp. extracts. Baghdad Sci J. 17(452-462.

[43] Radhika, R. (2021). Antibacterial activity of Ganoderma lucidum extracts against MDR pathogens. International Journal of Modern Agriculture. 10(2), 3488-3493.

[44] Heleno, S. A., Ferreira, I. C., Esteves, A. P., Ćirić, A., Glamočlija, J., Martins, A., . . . Queiroz, M. J. R. (2013). Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food and chemical toxicology. 58(95-100.

[45] Quereshi, S., Pandey, A. &  Sandhu, S. (2010). Evaluation of antibacterial activity of different Ganoderma lucidum extracts. J Sci Res. 3(9-13.

[46] Shah, P., Modi, H., Shukla, M. &  Lahiri, S. K. (2014). Preliminary phytochemical analysis and antibacterial activity of Ganoderma lucidum collected from Dang District of Gujarat, India. International Journal of Current Microbiology and Applied Sciences. 3(3), 246-255.

[47] Sridhar, S., Sivaprakasam, E., Balakumar, R. &  Kavitha, D. (2011). Evaluation of antibacterial and antifungal activity of Ganoderma lucidum (Curtis) P. Karst fruit bodies extracts. World Journal of Science and Technology Research. 1(6), 8-11.

[48] Bitew, A. & Abate, D. (1994). Antifungal metabolites from submerged culture of Ganoderma Lucidum (Polypore). Ethiopian Journal of Health Development. 8(1),

[49] Al-Easawi, N. A. F. & Rusol, M. (2016). Vehicle Indoor Air pollution with fungi generated by Air Conditioning systems (AC) and treatment by using Aqueous Extracts Mushroom (Ganoderma lucidum). Iraqi Journal of Science, 1096-1102.

[50] Saludares, G., Amper, C. &  Lituanas, I. (2023). Antimicrobial performances of Ganoderma lucidum extract against fruits and leaves pathogens. in IOP Conference Series: Earth and Environmental Science.

[51] Al-Qassab, H. S. & Utba, N. (2022). Human Immunodeficiency Virus Genotyping in Baghdad, Iraq. Indian Journal of Ecology. 49(318-323.

[52] Li, Y.-Q. & Wang, S.-F. (2006). Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnology letters. 28(837-841.

[53] Eo, S.-K., Kim, Y.-S., Lee, C.-K. &  Han, S.-S. (1999). Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. Journal of Ethnopharmacology. 68(1-3), 129-136.

[54] Bharadwaj, S., Lee, K. E., Dwivedi, V. D., Yadava, U., Panwar, A., Lucas, S. J., . . . Kang, S. G. (2019). Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Scientific reports. 9(1), 19059.

[55] Al-Jumaili, M. M. O., Al-Dulaimi, F. &  Ajeel, M. A. (2020). The role of Ganoderma lucidum uptake on some hematological and immunological response in patients with coronavirus (COVID-19). Systematic Review in Pharmacy. 11(8), 537-541.

[56] Assim, M. M. & Saheb, E. J. (2018). The association of severe toxoplasmosis and some cytokine levels in breast cancer patients. Iraqi Journal of Science, 1189-1194.

[57] Siegel, R., Ma, J., Zou, Z. &  Jemal, A. (2014). Cancer statistics, 2014. CA: a cancer journal for clinicians. 64(1),

[58] Schirrmacher, V. (2019). From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. International journal of oncology. 54(2), 407-419.

[59] Kladar, N. V., Gavaric, N. S. &  Božin, B. N. (2016). Ganoderma: insights into anticancer effects. European Journal of Cancer Prevention. 25(5), 462-471.

[60] Weng, C.-J. & Yen, G.-C. (2010). The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clinical & experimental metastasis. 27(361-369.

[61] CI, M. (2006). Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia Research. 30(841-848.

[62] Sadava, D., Still, D. W., Mudry, R. R. &  Kane, S. E. (2009). Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Letters. 277(2), 182-189.

[63] Yue QingXi, Y. Q., Guan ShuHong, G. S., Xie FuBo, X. F., Song XiaoYi, S. X., Ma Chao, M. C., Feng LiXing, F. L., . . . Guo DeAn, G. D. (2008). Interaction of Ganoderma triterpenes with docetaxel and cisplatin in cytotoxicity against human carcinoma cells.

[64] Mahdi, M. A., Dawood, Y. J., Sabah, R. S. &  Abd Al-Rahman, S. (2024). Evaluation of Oxidative Stress, Anti-Oxidant, Vitamins and Co-Factor Elements in The Sera of Gastric Cancer in Iraqi Patients. Asian Pacific Journal of Cancer Prevention: APJCP. 25(10), 3651.

[65] Mahdi, Q. A., Wadood, S. A. &  Hamza, R. H. (2019). Association Between Systemic and Local Oxidative Stress of Infertile Women Undergoing Ivf/Icsi. Iraqi Journal of Science, 1888-1897.

[66] Lee, J. M., Kwon, H., Jeong, H., Lee, J. W., Lee, S. Y., Baek, S. J. &  Surh, Y. J. (2001). Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 15(3), 245-249.

[67] Jia, J., Zhang, X., Hu, Y.-S., Wu, Y., Wang, Q.-Z., Li, N.-N., . . . Dong, X.-C. (2009). Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chemistry. 115(1), 32-36.

[68] Kan, Y., Chen, T., Wu, Y. &  Wu, J. (2015). Antioxidant activity of polysaccharide extracted from Ganoderma lucidum using response surface methodology. International journal of biological macromolecules. 72(151-157.

[69] Ma, H.-T., Hsieh, J.-F. &  Chen, S.-T. (2015). Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 114(109-113.

[70] Agius, L. (2007). New hepatic targets for glycaemic control in diabetes. Best Practice & Research Clinical Endocrinology & Metabolism. 21(4), 587-605.

[71] Xiao, C., Wu, Q.-P., Cai, W., Tan, J.-B., Yang, X.-B. &  Zhang, J.-M. (2012). Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Archives of pharmacal research. 35(1793-1801.

[72] Oliver-Krasinski, J. M., Kasner, M. T., Yang, J., Crutchlow, M. F., Rustgi, A. K., Kaestner, K. H. &  Stoffers, D. A. (2009). The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. The Journal of clinical investigation. 119(7), 1888-1898.

[73] Civeira, F. & Hypercholesterolemia, I. P. o. M. o. F. (2004). Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 173(1), 55-68.

[74] Meneses, M. E., Martínez-Carrera, D., Torres, N., Sánchez-Tapia, M., Aguilar-López, M., Morales, P., . . . Granados-Portillo, O. (2016). Hypocholesterolemic properties and prebiotic effects of Mexican Ganoderma lucidum in C57BL/6 mice. Plos one. 11(7), e0159631.

[75] Ahmad, M. F., Ahmad, F. A., Zeyaullah, M., Alsayegh, A. A., Mahmood, S. E., AlShahrani, A. M., . . . Elbendary, E. Y. (2023). Ganoderma lucidum: novel insight into hepatoprotective potential with mechanisms of action. Nutrients. 15(8), 1874.

[76] Oluwafemi Adetuyi, B., Olamide Okeowo, T., Adefunke Adetuyi, O., Abraham Adebisi, O., Ogunlana, O. O., Janet Oretade, O., . . . Batiha, G. E.-S. (2020). Ganoderma lucidum from red mushroom attenuates formaldehyde-induced liver damage in experimental male rat model. Biology. 9(10), 313.

[77] Peng, H., Zhong, L., Cheng, L., Chen, L., Tong, R., Shi, J. &  Bai, L. (2023). Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis. Frontiers in pharmacology. 13(1094405.

[78] Cao, Y.-J., Huang, Z.-R., You, S.-Z., Guo, W.-L., Zhang, F., Liu, B., . . . Liu, P.-H. (2022). The protective effects of ganoderic acids from Ganoderma lucidum fruiting body on alcoholic liver injury and intestinal microflora disturbance in mice with excessive alcohol intake. Foods. 11(7), 949.